Dr. David Michael Straughan, MD

Dr. Straughan practices at Lakeland Regional Health Systems, Inc. in Lakeland, Florida.

Dr. Straughan's NPI, 1861711053, was assigned on May 27, 2010. Dr. Straughan graduated from McGovern Medical School in 2010. Dr. Straughan holds Florida license ME149012.

Dr. Straughan's primary practice is Lakeland Regional Health Systems, Inc., at 3525 Lakeland Hills Blvd, Lakeland, FL 33805 in Polk County. The practice phone is (863) 687-7251.

Dr. Straughan's primary practice is Lakeland Regional Health Systems, Inc. in Lakeland, Florida. Dr. Straughan is also affiliated with Lakeland Regional Health Medical Center. The medical group on file is Lakeland Regional Health.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Straughan practices. Vendor and product names are available with a free account.

Plastic and reconstructive surgery is Dr. Straughan's primary specialty in the NPI Registry, under taxonomy code 2086S0122X. Dr. Straughan is board certified in plastic surgery by the American Board of Plastic Surgery. Dmand AI has Dr. Straughan's licenses on file in 4 states: Florida, Massachusetts, Louisiana and Virginia.

Dmand AI lists breast reconstruction and cancerous skin growth removal among the conditions Dr. Straughan treats.

CMS data shows 61 Medicare services from Dr. Straughan across 3 procedure codes in 2024, for 61 Medicare patients. Medicare paid $7,560 for them.

CMS counts 61 Medicare patients who saw Dr. Straughan in 2024. The largest group is 65 to 74, with 22 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 20% are also on Medicaid. Their average risk score is 2.33, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Straughan's median patient age at 52, with 82% women.

In 2024, Dr. Straughan wrote 96 Medicare Part D claims for 50 patients. 100% of them were for generic drugs. CMS names the drug for 74 of them, across 3 drugs with 11 or more claims each, at $390 in total drug cost. In 2023, CMS named 95 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Straughan for performance year 2024, reported as part of a group. Dr. Straughan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 27 procedures of mastectomy by Dr. Straughan, more than 84% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 24 papers to Dr. Straughan, published from 2015 to 2021. 2015 was the busiest year, with 7. The most frequent topics are Lung Neoplasms, Abdominoplasty and Carotid Body Tumor. Dr. Straughan has published most often in Aesthetic Plast Surg. Dr. Straughan's most frequent co-authors are Emily Susan Reardon, MD, Michael J. Yaremchuk, MD and Said Charbel Azoury, SAID, Azoury.

CMS Open Payments shows 17 general payments to Dr. Straughan from 7 drug and device companies from 2016 to 2025. Grants make up the largest share, 86% of the total. KLS-Martin L.P. paid the most, $7,500.

Dr. Straughan graduated from McGovern Medical School in 2010.

Dr. Straughan is in network with 20 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 12. Check the plan with the practice before a visit.